A Vaccine Made From a Person's Own Immune Cells for Brain Tumors
Original title: Immune Modulatory DC Vaccine Against Brain Tumor
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is an early safety test in people.
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study tests a vaccine built from a person's own immune cells.
Who this trial is for. This trial is for people with brain cancer, including glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary (GBM) and DIPG. It tests a vaccine made from a person's own immune cells, mixed with tumor cells or tumor markers.
Where it stands. The study is checking how safe the vaccine is. It is also checking if the vaccine may help. The trial has not reported results. The answer is not in yet.
What this means, and what it doesn't
What it could mean: Some people with these brain tumors may want to learn more. You can ask your care team about this study. They can help you decide if it makes sense to look into.
What it doesn't mean: This does not mean the vaccine works. A trial is a test, not a proven treatment. Being in one does not promise any benefit. It is not a cure.
Source: ClinicalTrials.gov, August 26, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.